Extremely significant positive changes in Ohio Valley Banc Corp. (NASDAQ: OVBC) investment behavior have recently occurred: the stock rose on very heavy volume, and its shorter term price trend turned up. Significant positive changes in […]
For its fourth fiscal quarter (ending December 31), Norwegian Cruise Line Holdings L (NYSE: NCLH) has reported a -332% decline in E.P.S. from $-0.25 a year ago to $0.58 in the current quarter. For the […]
For its fourth fiscal quarter (ending December 31), MasTec Inc. (NYSE: MTZ) has reported a 9500% increase in E.P.S. from $0.01 a year ago to $0.96 in the current quarter. E.P.S. were $2.09 for the […]
LeMaitre Vascular Inc (NASDAQ: LMAT) has reported E.P.S. of $0.50 for its fourth fiscal quarter (ending December 31) versus $0.38 for the same period a year ago — an increase of 32%. For the latest […]
HP Inc (NYSE: HPQ) has reported E.P.S. of $0.60 for its first fiscal quarter (ending January 31) versus $0.63 for the same period a year ago — a decline of -5%. For the latest four […]
Globalstar Inc (NASDAQ: GSAT) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.03 versus a loss $-0.01 for the same period a year ago — an increase of 200%. For […]
On 2/27/25, Digimarc Corp (NASDAQ: DMRC) stock suffered a major decline of -43.1%, closing at $15.39. Moreover, this decline was accompanied by exceptionally high trading volume at 769% of normal. The stock has declined -47.5% […]
For its fourth fiscal quarter (ending December 31), Ameresco Inc (NYSE: AMRC) has reported a 9% increase in E.P.S. from $0.65 a year ago to $0.71 in the current quarter. E.P.S. were $1.08 for the […]
For its fourth fiscal quarter (ending December 31), Warner Bros. Discovery Inc (NASDAQ: WBD) has reported a 25% increase in E.P.S. from $-0.16 a year ago to $-0.20 in the current quarter. E.P.S. were $-4.62 […]
The Marcus Corp (NYSE: MCS) stock suffered a major decline of -11.2% on 2/27/25. The shares closed at $18.54. Moreover, trading volume in this decline was unusually high at 196% of normal. Relative to the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research